Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects

References

• Au KM, Satterlee A, Min Y, et al. (2016). Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic. Biomaterials 82:178–93.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. (2014). Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25.
   PubMed Web of Science ®Google Scholar
• Chang D, Gao Y, Wang L, et al. (2016). Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. J Colloid Interface Sci 463:279–87.
   PubMed Web of Science ®Google Scholar
• Dai J, Lin S, Cheng D, et al. (2011). Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed Engl 50:9404–8.
   PubMed Web of Science ®Google Scholar
• Feng L, Liu L, Lv F, et al. (2014). Preparation and biofunctionalization of multicolor conjugated polymer nanoparticles for imaging and detection of tumor cells. Adv Mater 26:3926–30.
   PubMed Web of Science ®Google Scholar
• Geszke M, Murias M, Balan L, et al. (2011). Folic acid-conjugated core/shell ZnS:Mn/ZnS quantum dots as targeted probes for two photon fluorescence imaging of cancer cells. Acta Biomater 7:1327–38.
   PubMed Web of Science ®Google Scholar
• Gu X, Zhang Y, Sun H, et al. (2015). Mussel-inspired polydopamine coated iron oxide nanoparticles for biomedical application. J Nanomater 2015:3.
   Web of Science ®Google Scholar
• Gullotti E, Yeo Y. (2012). Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles. J Control Release 164:170–6.
   PubMed Web of Science ®Google Scholar
• He S, Cen B, Liao L, et al. (2017). A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Deliv 24:471–81.
   PubMed Web of Science ®Google Scholar
• Hong S, Na YS, Choi S, et al. (2012). Non-covalent self-assembly and covalent polymerization co-contribute to polydopamine formation. Adv Funct Mater 22:4711–7.
   Web of Science ®Google Scholar
• Ibrahim SS, Osman R, Mortada ND, et al. (2017). Passive targeting and lung tolerability of enoxaparin microspheres for a sustained antithrombotic activity in rats. Drug Deliv 24:243–51.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Xiao Z, Valencia PM, et al. (2012). Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41:2971–3010.
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Coll Surf B-Biointerfaces 75:1–18.
   PubMed Web of Science ®Google Scholar
• Lee H, Dellatore SM, Miller WM, Messersmith PB. (2007). Mussel-inspired surface chemistry for multifunctional coatings. Science 318:426–30.
   PubMed Web of Science ®Google Scholar
• Lee H, Rho J, Messersmith PB. (2009). Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings. Adv Mater Weinheim 21:431–4.
   PubMed Web of Science ®Google Scholar
• Li J, Wang FS, Sun DQ, Wang RM. (2016). A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours. J Drug Target 24:590–602.
   PubMed Web of Science ®Google Scholar
• Liu G, Tsai HI, Zeng XW, et al. (2017a). Phosphorylcholine-based stealthy nanocapsules enabling tumor microenvironment-responsive doxorubicin release for tumor suppression. Theranostics 7:1192–203.
   PubMed Web of Science ®Google Scholar
• Liu L, Yao W, Rao Y, et al. (2017b). pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms. Drug Deliv 24:569–81.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu X, Mi YS, et al. (2017c). PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies. Drug Deliv 24:443–51.
   PubMed Web of Science ®Google Scholar
• Liu R, Guo Y, Odusote G, et al. (2013a). Core-shell Fe3O4 polydopamine nanoparticles serve multipurpose as drug carrier, catalyst support and carbon adsorbent. ACS Appl Mater Interfaces 5:9167–71.
   PubMed Web of Science ®Google Scholar
• Liu XS, Cao JM, Li H, et al. (2013b). Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo. Acs Nano 7:9384–95.
   PubMed Web of Science ®Google Scholar
• Liu S, Fu J, Wang M, et al. (2016). Magnetically separable and recyclable Fe 3 O 4–polydopamine hybrid hollow microsphere for highly efficient peroxidase mimetic catalysts. J Coll Interface Sci 469:69–77.
   PubMed Web of Science ®Google Scholar
• Luo Z, Cai KY, Hu Y, et al. (2012). Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity. Adv Healthcare Mater 1:321–5.
   Web of Science ®Google Scholar
• Mei L, Zhang Z, Zhao L, et al. (2013). Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev 65:880–90.
   PubMed Web of Science ®Google Scholar
• Narayanan S, Binulal NS, Mony U, et al. (2010). Folate targeted polymeric ‘green’ nanotherapy for cancer. Nanotechnology 21:285107.
   PubMed Web of Science ®Google Scholar
• Park J, Brust TF, Lee HJ, et al. (2014). Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers. ACS Nano 8:3347–56.
   PubMed Web of Science ®Google Scholar
• Porta F, Lamers GE, Morrhayim J, et al. (2013). Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery. Adv Healthc Mater 2:281–6.
   PubMed Web of Science ®Google Scholar
• Postma A, Yan Y, Wang YJ, et al. (2009). Self-polymerization of dopamine as a versatile and robust technique to prepare polymer capsules. Chem Mater 21:3042–4.
   Web of Science ®Google Scholar
• Puligujja P, Balkundi SS, Kendrick LM, et al. (2015). Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials 41:141–50.
   PubMed Web of Science ®Google Scholar
• Shaw TK, Mandal D, Dey G, et al. (2017). Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Drug Deliv 24:346–57.
   PubMed Web of Science ®Google Scholar
• Song Q, Chuan XX, Chen BL, et al. (2016). A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells. Drug Deliv 23:1734–46.
   PubMed Web of Science ®Google Scholar
• Su J, Chen F, Cryns VL, Messersmith PB. (2011). Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J Am Chem Soc 133:11850–3.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Yoshino T, Matsunaga T. (2010). Surface modification of magnetic nanoparticles using asparagines-serine polypeptide designed to control interactions with cell surfaces. Biomaterials 31:4952–7.
   PubMed Web of Science ®Google Scholar
• Tao W, Zeng X, Liu T, et al. (2013). Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Acta Biomater 9:8910–20.
   PubMed Web of Science ®Google Scholar
• Tao W, Zeng X, Zhang J, et al. (2014). Synthesis of cholic acid-core poly (ε-caprolactone-ran-lactide)-b-poly (ethylene glycol) 1000 random copolymer as a chemotherapeutic nanocarrier for liver cancer treatment. Biomater Sci 2:1262–74.
   PubMed Web of Science ®Google Scholar
• Tao W, Zeng XW, Wu J, et al. (2016). Polydopamine-based surface modification of novel nanoparticle-aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects. Theranostics 6:470–84.
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hola K, Subr V, et al. (2016). Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev 116:5338–431.
   PubMed Web of Science ®Google Scholar
• Wang C, Cheng L, Liu Z. (2011). Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 32:1110–20.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhu D, Liu G, et al. (2015). DTX-loaded star-shaped TAPP-PLA-b-TPGS nanoparticles for cancer chemical and photodynamic combination therapy. RSC Adv 5:50617–27.
   Web of Science ®Google Scholar
• Yang B, Ni X, Chen L, et al. (2017). Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma. Drug Deliv 24:660–9.
   PubMed Web of Science ®Google Scholar
• Yu F, Ao M, Zheng X, et al. (2017). PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv 24:825–33.
   PubMed Web of Science ®Google Scholar
• Zeng X, Liu G, Tao W, et al. (2017). A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond. Adv Funct Mater 27:1605985.
   Web of Science ®Google Scholar
• Zeng XW, Tao W, Mei L, et al. (2013). Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 34:6058–67.
   PubMed Web of Science ®Google Scholar
• Zeng XW, Tao W, Wang ZY, et al. (2015). Docetaxel-loaded nanoparticles of dendritic amphiphilic block copolymer H40-PLA-b-TPGS for cancer treatment. Part Part Syst Charact 32:112–22.
   Web of Science ®Google Scholar
• Zhang C, Zhang Z, Zhao LQ. (2016). Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity. Drug Deliv 23:1830–7.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liang X, Gu J, et al. (2017). Investigation and intervention of autophagy to guide cancer treatment with nanogels. Nanoscale 9:150–63.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Yang Y, Liang X, et al. (2014). Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics 4:1085–95.
   PubMed Web of Science ®Google Scholar
• Zhao H, Chao Y, Liu J, et al. (2016). Polydopamine coated single-walled carbon nanotubes as a versatile platform with radionuclide labeling for multimodal tumor imaging and therapy. Theranostics 6:1833.
   PubMed Web of Science ®Google Scholar
• Zhou K, Wang Y, Huang X, et al. (2011). Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. Angew Chem Int Ed Engl 50:6109–14.
   PubMed Web of Science ®Google Scholar
• Zhu D, Tao W, Zhang H, et al. (2016). Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater 30:144–54.
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. (2014). Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials 35:2391–400.
   PubMed Web of Science ®Google Scholar